IPO Profile: Versartis Inc

Advent Life Sciences, Aisling Capital, Amunix, Fidelity, Index Ventures, New Leaf Ventures and Sofinnova Venture Partners own 14,770,487 shares worth about $310 million at the IPO price.

11 April 2014•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail